Skip to main content
SpringerLink
Log in

The strength of a randomized controlled trial lies in its design—randomization

  • Letter to the Editor
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Garg PK, Kaul P, Choudhary D, Turaga KK, Singh MP, Tiwari AR, Arora V, Agrawal N, Rau B, Yendamuri S (2020) Discordance of COVID-19 guidelines for patients with cancer: A systematic review. J Surg Oncol 122:579–593

    Article  CAS  Google Scholar 

  2. Bhide A, Shah PS, Acharya G (2018) A simplified guide to randomized controlled trials. Acta Obstet Gynecol Scand 97:380–387

    Article  Google Scholar 

  3. Choudhary D, Garg PK (2011) Primary outcome in a randomized controlled trial: A critical issue. Saudi J Gastroenterol 17:369

    PubMed  PubMed Central  Google Scholar 

  4. Mohanty D, Garg PK, Kumar A (2013) Intention to treat analysis: Are we really doing it? World J Surg 37:1181–1182

    Article  Google Scholar 

  5. Pinto E, Nardi MT, Marchi R, Cavallin F, Alfieri R, Saadeh L, Cagol M, Baldan I, Saraceni E, Parotto M, Baratto F, Caberlotto C, Vianello A, Castoro C, Scarpa M (2021) QOLEC2: A randomized controlled trial on nutritional and respiratory counseling after esophagectomy for cancer. Support Care Cancer 29:1025–1033

    Article  Google Scholar 

  6. Dettori J (2010) The random allocation process: Two things you need to know. Evid Based Spine Care J 1:7–9

    Article  Google Scholar 

  7. Dumville JC, Hahn S, Miles JN, Torgerson DJ (2006) The use of unequal randomisation ratios in clinical trials: A review. Contemp Clin Trials 27:1–12

    Article  CAS  Google Scholar 

  8. Hey SP, Kimmelman J (2014) The questionable use of unequal allocation in confirmatory trials. Neurology 82:77–79

    Article  Google Scholar 

  9. Ghi MG, Paccagnella A, Ferrari D, Foa P, Alterio D, Codeca C, Nole F, Verri E, Orecchia R, Morelli F, Parisi S, Mastromauro C, Mione CA, Rossetto C, Polsinelli M, Koussis H, Loreggian L, Bonetti A, Campostrini F, Azzarello G, D’Ambrosio C, Bertoni F, Casanova C, Emiliani E, Guaraldi M, Bunkheila F, Bidoli P, Niespolo RM, Gava A, Massa E, Frattegiani A, Valduga F, Pieri G, Cipani T, Da Corte D, Chiappa F, Rulli E, Group GIS (2017) Induction TPF followed by concomitant treatment versus concomitant treatment alone in locally advanced head and neck cancer. A phase II-III trial. Ann Oncol 28:2206–2212

    Article  CAS  Google Scholar 

  10. Garg PK, Kaul P, Choudhary D (2020) Intention-to-treat analysis in precision oncology: A cautious interpretation. Eur J Cancer 138:229–231

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgical Oncology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, 249203, India

    Pallvi Kaul, Bodhisattva Bose, Rahul Kumar, Ipsit Ilahi & Pankaj Kumar Garg

Authors
  1. Pallvi Kaul
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bodhisattva Bose
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rahul Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ipsit Ilahi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Pankaj Kumar Garg
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pankaj Kumar Garg.

Ethics declarations

Ethics approval

Not required

Consent to participate

Not applicable

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kaul, P., Bose, B., Kumar, R. et al. The strength of a randomized controlled trial lies in its design—randomization. Support Care Cancer 30, 4573–4575 (2022). https://doi.org/10.1007/s00520-021-06163-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-021-06163-3

Search

Navigation